FDA has published a draft overhaul of the 1999 document dealing with pre-IDE submissions, substantially expanding the scope of the program to include devices co-regulated by the Center for Biologics Evaluation and Research, but FDA is also offering pre-submission interaction for 510(k) applications as well. Read More
